-- Post hoc analysis of UPLIZNA Phase 2/3 trial shows all seven patients who had attacks while receiving rituximab were attack-free after switching to UPLIZNA -- UPLIZNA is the first and only ...

Bipolar disorder appears to be more common in people with multiple sclerosis (MS) than in the general population. MS is an autoimmune condition that affects the brain and spinal cord, damaging nerves ...

A new study published in Multiple Sclerosis and Related Disorders highlights the potential of "More Stamina," a gamified ...

Demyelinating diseases of the central nervous system (CNS), including multiple sclerosis (MS) and related inflammatory and degenerative disorders, represent ...

Managing multiple sclerosis (MS) is not a straight path. From getting diagnosed to treating symptoms, it’s a journey of ups and downs. Nearly one million people in the United States have MS and ...

—Evidence from a recent study found that improvement in depression symptoms was associated with a reduction in physical, cognitive, and social fatigue in patients with multiple sclerosis. As ...

This activity was supported by Contract No. VA241-P-2024/VA119A-15-J-0030 from the U.S. Department of Veterans Affairs. Any opinions, findings, conclusions, or ...

MS treatments during pregnancy do not seem to increase the risk of neurodevelopmental disorders in exposed children, a study ...

Multiple sclerosis (MS) is characterized by a broad array of symptoms. Despite this variability, most individuals with MS will exhibit a distinct set of symptoms during their initial clinical attack.